NCR3 and neoplasm: The IL-15-mediated expansion of NK cells and their anti-tumor effector functions, mediated via antibody-dependent cellular cytotoxicity and the expression of other receptors involved in tumor cell killing, including NKG2D, NKp30 and DNAM-1, are attenuated by TGF-β1.